Patient Navigator
OtherSocial worker/Patient Navigator will be assigned to follow youth in adult care for up to 24 months to assist youth adapt and attach to adult delivered healthcare
NCT Number: NCT03342495
The Transition Navigator Trial (TNT) is a pragmatic randomized controlled trial evaluating the effectiveness of usual care plus a patient navigator service versus usual care plus newsletters and other educational materials, to improve transition outcomes among adolescents aged 16-21 who have chronic health conditions requiring transfer to adult specialty care.
The study will provide urgently needed data to guide health care providers and policy makers regarding the provision of coordinated transition care. These results have the potential to:
1. Change care delivery 2. Improve health outcomes 3. Improve the experiences of young adult transition to adult care
Looking for future studies?
Notify Me16 year–21 year
All sexes
Interventional
Not applicable
Alberta Children's Hospital, Calgary, Alberta, Canada
Transition is the purposeful, planned movement of adolescent and young adults with chronic health conditions from child-centered to adult-oriented health systems. Transition includes, but is not limited to transfer to adult care. Transfer of care, which occurs during a vulnerable developmental period around age 18 introduces gaps in continuity of care that can lead to detrimental health outcomes in young adults. Therefore, provision of coordinated and developmentally appropriate care during the transition period is necessary to maintain health and to sustain investments made in pediatric health care.
Clinical practice guidelines for transition to adult care recommend the use of patient navigators to coordinate the entry of patients into a complex and unfamiliar adult health care system. Patient navigators provide individualized supports to facilitate medical follow-up and adherence. A limited number of studies have shown that access to a patient navigator during transition decreases drop-out from medical care and disease specific adverse events. No study to date has evaluated the benefits of a patient navigator to improve patient and or health system outcomes, when implemented across multiple chronic disease settings.
Objectives/Methods
A qualitative study sampling participants randomized into the intervention arm at the beginning and end of the trial will also be undertaken to understand the patient experience.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Social worker/Patient Navigator will be assigned to follow youth in adult care for up to 24 months to assist youth adapt and attach to adult delivered healthcare
Whatever processes are in place in a variety of clinics to support transfer from pediatric to adult care in the pediatric clinics
Time frame: 12 to 24 months
verification of health services utilized by up to 600 participants collected via personal health numbers (e.g. National Ambulatory Care Reporting System; Alberta Ambulatory Care Reporting System; Discharge Abstract Database; Physician Claims)
Time frame: up to 24 months
did the intervention save high cost service provision
Time frame: Enrollment and 3 subsequent times in 24 months
Variation in TRAQ scores; comparing intervention and non-intervention arm
Time frame: Enrollment and 3 subsequent times in 24 months
Participant reported mental and physical health
Time frame: after 12 to 24 months
Qualitative Interviews with sampling of participants from patient navigator intervention arm
University of Calgary
Other
Acronym: TNT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05014204
Diabetes, Diabetes Mellitus
Los Angeles, California, United States
View Trial DetailsNCT00017953
Behavior, Behavioral Symptoms
Birmingham, Alabama, United States
View Trial DetailsNCT03675360
Diabetes, Diabetes Mellitus
New Orleans, Louisiana, United States
View Trial DetailsNCT03945968
Alzheimer Disease, Alzheimer's Disease
Arkhangelsk, Russia
View Trial Details